[{"NetIncomeLoss_1_Q2_USD":-32393000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":11526000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":53369000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":51938000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":15374000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":155000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":49006000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":150411000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2586815.0,"AssetsCurrent_0_Q2_USD":446367000.0,"MarketableSecuritiesRealizedGainLoss_2_Q2_USD":0.0,"ContractWithCustomerLiability_0_Q2_USD":100679000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":22840000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":7829000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":1035000.0,"CommonStockSharesIssued_0_Q2_shares":58724238.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":75117000.0,"Assets_0_Q2_USD":490830000.0,"ShareBasedCompensation_2_Q2_USD":8921000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":23469000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":16.82,"ProceedsFromIssuanceOfCommonStock_25_Q2_USD":889800000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":8.16,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":9.04,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":564000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7829000.0,"CommonStockSharesAuthorized_0_Q2_shares":120000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":14.63,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":15.05,"ResearchAndDevelopmentExpense_2_Q2_USD":72421000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":37771000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":15.03,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2_Q2_shares":181020.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":2434000.0,"ProceedsFromStockPlans_2_Q2_USD":685000.0,"AccountsReceivableNetCurrent_0_Q2_USD":3864000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.673,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q2_pure":0.702,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q2_USD":17.31,"CommonStockValue_0_Q2_USD":6000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":3107000.0,"MarketableSecuritiesCurrent_0_Q2_USD":75117000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":137089000.0,"CostsAndExpenses_1_Q2_USD":49297000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":183500000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-64305000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-32611000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-3899000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.009,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q2_pure":0.004,"OtherAssetsNoncurrent_0_Q2_USD":4592000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":361687000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":17349000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":716503000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q2_shares":248485.0,"CostsAndExpenses_2_Q2_USD":95261000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":29179000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":16263000.0,"OperatingIncomeLoss_2_Q2_USD":-66082000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-756000.0,"CommonStockSharesOutstanding_0_Q2_shares":58724238.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":31208000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":5674000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-218000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":155000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4764000.0,"MarketableSecuritiesUnrealizedGainLoss_2_Q2_USD":-106000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":-218000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":18872000.0,"LiabilitiesCurrent_0_Q2_USD":59142000.0,"AccountsPayableCurrent_0_Q2_USD":7000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":306372000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":5699000.0,"ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_2_Q2_USD":87477000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":645000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-239000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":363598000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":137210.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":685000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":432000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_25_Q2_USD":85000000.0,"RestrictedCashEquivalents_0_Q2_USD":1911000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":22023000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":16402000.0,"NetIncomeLoss_2_Q2_USD":-64199000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1370000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-365077000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":3114690.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":7581040.0,"OperatingIncomeLoss_1_Q2_USD":-33034000.0,"ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_2_Q2_USD":-15608000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":800000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q2_USD":500000.0,"InvestmentIncomeInterest_2_Q2_USD":1883000.0,"InvestmentIncomeInterest_1_Q2_USD":641000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":0.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":37927000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":13.59,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":9.99,"LiabilitiesAndStockholdersEquity_0_Q2_USD":490830000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":5677000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":8921000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4764000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":39100000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":234536.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":5834000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_0_Q2_USD":2300000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.24,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.61,"ProfitLoss_2_Q2_USD":-64199000.0,"StockholdersEquity_0_Q2_USD":351587000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":62752000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1881000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":74962000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":268000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":71869000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1892000.0,"Ticker":"NTLA","CIK":"1652130","name":"INTELLIA THERAPEUTICS, INC.","OfficialName":"Intellia Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"4259315236.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]